Doximity, Inc. ($DOCS) Stock Forecast: Down 5.0% Today

What is Doximity, Inc.?

DOCS is the ticker symbol for Doximity Inc, a company that operates an online platform for medical professionals to collaborate and share information. The overall market sentiment for the stock has been bearish today.

Why is Doximity, Inc. going down?

DOCS stock is down 5.0% on Nov 14, 2024 17:48

• Doximity Inc reported strong Q2 earnings results, exceeding revenue and EPS estimates, leading to a surge in after-hours trading.
• Despite the positive earnings report, a notable analyst downgraded the rating for Doximity, which may have contributed to the bearish movement in the stock.
• The comparison with other medical stocks like CareDx (CDNA) in the sector may have highlighted relative underperformance, impacting investor sentiment.
• It's possible that profit-taking or market dynamics unrelated to the company's performance also played a role in the bearish movement of DOCS today.

DOCS Price Chart

DOCS Technical Analysis

DOCS News

Are Medical Stocks Lagging CareDx ( CDNA ) This Year?

Here is how CareDx (CDNA) and Doximity (DOCS) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2370377/are-medical-stocks-lagging-caredx-cdna-this-year

This Campbell Soup Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Campbell Soup ( NASDAQ:CPB )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

https://www.benzinga.com/24/11/41968177/this-campbell-soup-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday

This Caterpillar Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday - Caterpillar ( NYSE:CAT )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Canaccord Genuity analyst Richard Close downgraded the rating for Doximity, Inc.

https://www.benzinga.com/24/11/41938766/this-caterpillar-analyst-turns-bearish-here-are-top-5-downgrades-for-wednesday

Doximity Reports Strong Q2 Earnings Results, Shares Soar - Doximity ( NYSE:DOCS )

Doximity Inc DOCS shares are surging in Thursday's after-hours session after the company reported better-than-expected financial results for the second quarter. Q2 Revenue: $136.83 million, versus estimates of $127.15 million Q2 Adjusted EPS: 30 cents, versus estimates of 25 cents

https://www.benzinga.com/news/earnings/24/11/41829467/doximity-reports-strong-q2-earnings-results-shares-soar

Trending Today

Solana ($SOL) Crypto Forecast: Up 7.1% Today

Ethereum Classic ($ETC) Crypto Forecast: Up 6.6% Today

Ethereum ($ETH) Crypto Forecast: Up 9.1% Today

Memecoin ($MEME) Crypto Forecast: Up 5.2% Today

Stox ($STX) Crypto Forecast: Up 5.1% Today

XRP ($XRP) Crypto Forecast: Up 7.0% Today

FuelCell Energy ($FCEL) Stock Forecast: Down 5.2% Today

Riot Platforms, Inc. ($RIOT) Stock Forecast: Down 9.7% Today

Moderna Inc. ($MRNA) Stock Forecast: Up 5.4% Today

Spirit Airlines Inc ($SAVE) Stock Forecast: Down 19.0% Today

Doximity, Inc. Price History

08.10.2024 - DOCS Stock was up 38.9%

• Strong Q2 earnings results were recently announced by Doximity, surpassing both revenue and EPS projections.
• The company's shares have experienced a significant increase following the exceptional financial performance.
• Investors have responded favorably to Doximity's robust financial results, resulting in a rise in the stock price during after-hours trading.
• The impressive Q2 outcomes suggest that Doximity's business strategy and offerings are well-received by the market, boosting investor confidence and driving the stock's upward movement.

13.10.2024 - DOCS Stock was down 5.9%

• Despite reporting strong Q2 earnings results with revenue and adjusted EPS beating estimates, DOCS experienced a bearish movement.
• The bearish movement could be attributed to a recent downgrade by an analyst, which may have influenced investor sentiment negatively.
• Investors might have reacted to the downgrade more strongly than the positive earnings results, leading to the bearish movement in DOCS stock today.

14.10.2024 - DOCS Stock was down 5.7%

• Despite reporting strong Q2 earnings results with revenue and adjusted EPS beating estimates, DOCS experienced a bearish movement.
• The bearish movement could be attributed to a specific analyst downgrade by Canaccord Genuity, impacting investor sentiment negatively.
• It seems that even positive earnings results were overshadowed by the analyst's bearish outlook, leading to the stock's decline despite the strong performance.

14.10.2024 - DOCS Stock was down 5.0%

• Doximity Inc reported strong Q2 earnings results, exceeding revenue and EPS estimates, leading to a surge in after-hours trading.
• Despite the positive earnings report, a notable analyst downgraded the rating for Doximity, which may have contributed to the bearish movement in the stock.
• The comparison with other medical stocks like CareDx (CDNA) in the sector may have highlighted relative underperformance, impacting investor sentiment.
• It's possible that profit-taking or market dynamics unrelated to the company's performance also played a role in the bearish movement of DOCS today.

18.06.2024 - DOCS Stock was down 7.0%

• Doximity (DOCS) stock saw a -1.23% bearish movement.
• Possible profit-taking by investors following a period of notable gains might have influenced this downturn.
• Market sentiment appeared to be affected by broader economic worries or specific news relating to the healthcare technology industry.
• Investors could be reassessing their holdings in DOCS considering the company's growth potential and competitive environment.

24.06.2024 - DOCS Stock was down 5.1%

• The stock of Doximity (DOCS) experienced a strong bearish movement today, closing down by 1.23%.
• A downgrade for Doximity by analysts and an investigation initiated by a former Louisiana Attorney General into the company's officers and directors may have contributed to the negative market sentiment.
• Additionally, the company's recent disclosure of disappointing guidance for the 2Q 2024 and reduced full-year guidance could have further fueled investor concerns about Doximity's future performance.
• Investors are likely awaiting the release of Doximity's fiscal 2025 first-quarter results on August 8, 2024, for more insights into the company's financial health and outlook, which could potentially impact the stock's movement in the near term.

12.07.2024 - DOCS Stock was down 5.4%

• Doximity (DOCS) experienced a strong bearish movement today despite positive market news.
• The investigation into potential securities fraud may have raised concerns among investors, leading to a sell-off.
• Although Doximity reported better-than-expected financial results for the first quarter of Fiscal-Year 2024, the stock price still dropped significantly, indicating that other factors may have influenced the bearish trend.
• The overall market showed mixed trading, with some sectors like information technology performing well, while industrials fell slightly. This mixed market sentiment could have also contributed to the bearish movement in Doximity's stock.

09.07.2024 - DOCS Stock was up 34.2%

• Doximity shares surged by 28.6% in pre-market trading after reporting better-than-expected first-quarter financial results and issuing strong FY24 revenue guidance.
• The upgrade to a "buy" rating and a set price target on engagement uptick further fueled investor optimism in Doximity.
• The positive earnings report, with earnings per share and revenue beating analyst estimates, likely contributed to the bullish movement in DOCS stock.
• Despite the overall market fragility, Doximity's strong performance and optimistic outlook stood out, attracting investors' attention and driving the significant increase in the stock price.

12.07.2024 - DOCS Stock was down 6.0%

• Despite Doximity reporting better-than-expected financial results and a 35% spike in shares, the stock experienced a bearish movement.
• An investigation announced by Kaskela Law LLC on behalf of the company's long-term investors might have raised concerns and uncertainty among traders, leading to a sell-off.
• Comparison observations questioning the value of investing in DOCS versus other stocks could have also influenced market sentiment, contributing to the bearish movement.
• Profit-taking by investors who benefited from the recent stock rally played a role in the downward pressure on DOCS today.

09.07.2024 - DOCS Stock was up 37.6%

• Doximity's stock surged by 35.9% after reporting impressive second-quarter earnings that surpassed analysts' revenue expectations and provided a higher revenue guidance for the next quarter.
• The positive market movement could be attributed to the company's strong financial performance and exceeding key metrics, indicating solid growth potential.
• The bullish trend in Doximity's stock might also be influenced by the overall positive sentiment in the healthcare and technology sectors, as seen in the upbeat earnings of other companies like Expedia Group and Akamai Technologies.

09.07.2024 - DOCS Stock was up 33.6%

• Post-earnings, Doximity's stock saw a 30% increase, supported by an impressive adjusted EPS of 28 cents per share, which surpassed industry expectations.
• In fiscal Q1, the company generated $126.7 million in revenue, marking a 17% year-over-year growth, amplifying positive market sentiment.
• Analysts upgraded Doximity's shares to a buy rating and established a price target, attributing the rise in engagement and robust financial performance as catalysts for the optimistic outlook.
• The market's reaction to Doximity's earnings report highlights investor trust in the company's profitability prospects and its ability to engage a widening pool of healthcare providers, propelling the stock price upwards.

09.07.2024 - DOCS Stock was up 33.8%

• Doximity Inc. saw a surprising 40% stock rally, driven by positive market sentiment and strong investor interest in the company's growth potential.
• Meanwhile, ELF Beauty stock faced a 15% decline following its earnings report, despite beating earnings and revenue expectations. This unexpected drop may have contributed to a shift in focus towards DOCS stock.
• The bullish movement in DOCS could also be influenced by broader market trends and investor optimism in the tech sector.
• Additionally, the positive news surrounding Iovance Biotherapeutics and Marin Software may have created a ripple effect, boosting overall market sentiment and contributing to the bullish movement in DOCS stock.